Abdelhakim, Nashwa
Galecio-Castillo, Milagros
Kalakoti, Piyush
Cruz-Criollo, Leonardo
Rodriguez-Calienes, Aaron
Brito, Anderson
Cespedes, Jorge
Shaban, Amir
Venkatesan, Anish
Nigenda, Vanessa Cano
Pompa, Andres Alberto Mercado
Mohr, Nicholas M.
Pereda-Castillo, Adrian
Peregrino, Kevin EnrĂquez
Ruvalcaba, Hector Valdez
Smith, Brian J.
Torner, James C.
Barboza, Miguel A.
Arauz, Antonio
Ortega-Gutierrez, Santiago
Funding for this research was provided by:
the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (R03NS126804-01A1)
Article History
Received: 1 October 2025
Revised: 26 February 2026
Accepted: 13 March 2026
First Online: 14 April 2026
Declarations
:
: Santiago Ortega-Gutierrez receives Grants: NIH-NINDS, PCORI, Stryker, Medtronic, and Methinks; consultant for Medtronic and Stryker Neurovascular; National PI or CO-PI for US Tandem Registry, DONE SYMPLE, DIRECT, VOTER registry, ATHENA, SMAR-LVO. Institutional PI and Steering Committee: SEGA, TESLA, SELECT 2, SPLENDID, SUMMIT, MYSTIQUE. Holds Shares/Stock options on Brain Flow, Motif, Gravity, and EUREKA. Other authors declare no conflicts of interest.